Koyfin Home > Directory > Health Care > Aratana Theraptcs > Cost of Goods Sold

Aratana Theraptcs Cost of Goods Sold Chart (PETX)

Aratana Theraptcs annual/quarterly Cost of Goods Sold from 2013 to 2018.
  • Aratana Theraptcs Cost of Goods Sold for the quarter ending December 12, 2018 was $4m a 62.39% increase of 2m year over year
  • Aratana Theraptcs Cost of Goods Sold for the last 12 months ending December 12, 2018 was $11m a -51.51% decrease of -5m year over year
  • Aratana Theraptcs Annual Cost of Goods Sold for 2018 was $11m a -71.00% decrease of -8m from 2017
  • Aratana Theraptcs Annual Cost of Goods Sold for 2017 was $18m a 82.18% increase of 15m from 2016
  • Aratana Theraptcs Annual Cost of Goods Sold for 2016 was $3m a 86.16% increase of 3m from 2015
Other Income Statement Metrics:
  • Aratana Theraptcs EBITDA for the quarter ending December 12, 2018 was $-7m a 5.76% decrease of 0m year over year
  • Aratana Theraptcs Net Income for the quarter ending December 12, 2018 was $-9m a 1.00% decrease of 0m year over year
  • Aratana Theraptcs Total Revenue for the quarter ending September 09, 2018 was $22m a 51.49% increase of 11m year over year
View Chart On Koyfin

Quarterly PETX Cost of Goods Sold Data

12/2018$4m
09/2018$4m
06/2018$2m
03/2018$1m
12/2017$7m
09/2017$4m
06/2017$4m
03/2017$3m
12/2016$1m
09/2016$0m

Annual PETX Cost of Goods Sold Data

2018$11m
2017$18m
2016$3m
2015$0m
2014$0m
2013$0m